An individualized approach based on patient preferences is important for treatment of menopause.
A new review highlights a few differences among various once-weekly GLP-1 receptor agonists.
Central obesity in people with normal weight may increase the risk for premature mortality vs BMI-defined overweight or obesity.
Expert panel recommends continued use of SGLT2 inhibitors, as risk for DKA is low.
Guideline focuses on surgical resection to normalize cortisol levels.
Consensus group focuses on prevention and treatment of exercise-associated hyponatremia.